Skip to main content
OpenTrials

Clinical trial condition

Blood Protein Disorders

Explore clinical trials studying Blood Protein Disorders. Study availability and eligibility vary by location and protocol.

3,034 public trials 567 recruiting studies
Refine in advanced search Browse all conditions

Blood Protein Disorders trial results

Recruiting

Zanubrutinib, Bendamustine, Rituximab Prev. Untreated WM

NCT06561347

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Colorado Blood Cancer Institute (CBCI) Denver, Colorado, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Recruiting

Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple Myeloma

NCT03858205

Conditions
Blood Protein Disorders, Bone Pain, Cardiovascular Diseases, +15 more
Locations
  • City of Hope Duarte, California, United States
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Cedars Sinai Medical Center Los Angeles, California, United States
View Trial Details
Recruiting

A Study of Daratumumab

NCT05438043

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • University of Miami Sylvester Cancer Center Miami, Florida, United States
  • Emory University Atlanta, Georgia, United States
  • University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
  • Barnes-jewish Hospital St Louis, Missouri, United States
View all 92 locations
View Trial Details
Recruiting

Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation

NCT05243797

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Banner University Medical Center Tucson, University of Arizona Phoenix, Arizona, United States
  • UCLA Medical Center Los Angeles, California, United States
  • University of California-Davis Cancer Center Sacramento, California, United States
  • University of California, San Diego (UCSD) Medical Center San Diego, California, United States
View all 212 locations
View Trial Details
Recruiting

Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma

NCT06974786

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • University of Iowa Iowa City, Iowa, United States
  • University of North Carolina Chapel Hill, North Carolina, United States
View Trial Details

Related conditions